Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $43.60
Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 […]
Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 […]
